Find Federal Grants
New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
National Institutes of Health · PAR-25-272
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
National Institutes of Health · PAR-25-159
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
National Institutes of Health · PAR-25-158
Notice of Intent to Publish a Funding Opportunity Announcement for NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01)
National Institutes of Health · NOT-DA-24-052
Notice of Intent to Publish a Funding Opportunity Announcement for NINR Areas of Emphasis for Research to Optimize Health for All (R21 Clinical Trial Optional)
National Institutes of Health · NOT-NR-25-007
Notice of Intent to Publish a Funding Opportunity for NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
National Institutes of Health · NOT-DA-24-049
Notice of Intent to Publish a Notice of Funding Opportunity for Biomarkers of Cognitive Decline and Dementias of Aging in Individuals within the Autism Spectrum (U01 Clinical Trial Optional)
National Institutes of Health · NOT-AG-24-082
Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Diversity in Aging Research (ADAR) through Undergraduate Education Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health · NOT-AG-24-070
Notice of Intent to Publish a Funding Opportunity Announcement for NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34)
National Institutes of Health · NOT-DA-24-051
Notice of Intent to Publish a Funding Opportunity Announcement for Annual Conference in Therapeutics Development for Substance Use Disorders (U13 Clinical Trial Not Allowed)
National Institutes of Health · NOT-DA-25-033
Notice of Intent to Publish a Funding Opportunity Announcement for Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (R43/R44 Clinical Trial Optional)
National Institutes of Health · NOT-AA-24-015
Notice of Intent to Publish a Funding Opportunity Announcement for Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (R41/R42 Clinical Trial Optional)
National Institutes of Health · NOT-AA-24-014
Notice of Intent to Publish a Funding Opportunity for Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein NRSA Individual Postdoctoral Fellowship (F32)
National Institutes of Health · NOT-OD-25-006
Notice of Intent to Publish a Funding Opportunity for Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36)
National Institutes of Health · NOT-OD-25-007
Notice of Intent to Publish a Funding Opportunity Announcement for NINR Areas of Emphasis for Research to Optimize Health for All (R01 Clinical Trial Optional)
National Institutes of Health · NOT-NR-25-006
Ukraine USAID-Kiev · 72012125RFA00002
Centers for Disease Control and Prevention - ERA · RFA-JG-25-137
Monitoring, Operations Research, Evaluation of Tools for Malaria Control and Prevention in Kenya
Centers for Disease Control and Prevention - ERA · RFA-CK-25-035
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
National Institutes of Health · PAR-25-290
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
National Institutes of Health · PAR-25-291